Comparing concurrent chemoradiotherapy, 125I seed implantation combined with chemotherapy, and chemotherapy alone efficacy in treating unresectable locally advanced pancreatic cancer

Q4 Medicine Precision Radiation Oncology Pub Date : 2022-06-01 DOI:10.1002/pro6.1156
Ya-Qin Zheng, Rui Huang, Wen-Lu Zou, Chao Liu, H. Niu, J. Yue
{"title":"Comparing concurrent chemoradiotherapy, 125I seed implantation combined with chemotherapy, and chemotherapy alone efficacy in treating unresectable locally advanced pancreatic cancer","authors":"Ya-Qin Zheng, Rui Huang, Wen-Lu Zou, Chao Liu, H. Niu, J. Yue","doi":"10.1002/pro6.1156","DOIUrl":null,"url":null,"abstract":"The prognosis for unresectable locally advanced pancreatic cancer (LAPC) is still poor, and the best therapeutic option is still unknown. The common treatments for LAPC, concurrent chemoradiotherapy (CCRT), 125I seed implantation combined with chemotherapy (125IC), and chemotherapy alone (CA), were studied. In addition, we looked into the impact of radiation dose on the survival of patients receiving chemoradiotherapy.","PeriodicalId":32406,"journal":{"name":"Precision Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Precision Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pro6.1156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The prognosis for unresectable locally advanced pancreatic cancer (LAPC) is still poor, and the best therapeutic option is still unknown. The common treatments for LAPC, concurrent chemoradiotherapy (CCRT), 125I seed implantation combined with chemotherapy (125IC), and chemotherapy alone (CA), were studied. In addition, we looked into the impact of radiation dose on the survival of patients receiving chemoradiotherapy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
同期放化疗、125I粒子植入联合化疗和单纯化疗治疗不可切除的局部晚期癌症的疗效比较
不可切除的局部晚期胰腺癌(LAPC)预后仍然很差,最佳治疗选择仍然未知。研究了LAPC的常用治疗方法:同步放化疗(CCRT)、125I粒子植入联合化疗(125IC)和单独化疗(CA)。此外,我们还研究了放射剂量对接受放化疗的患者生存的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Precision Radiation Oncology
Precision Radiation Oncology Medicine-Oncology
CiteScore
1.20
自引率
0.00%
发文量
32
审稿时长
13 weeks
期刊最新文献
Treatment of Sinonasal Teratocarcinosarcoma: A case report Stereotactic body radiotherapy takes on Lung Oligometastases: Latest breakthroughs Clinical outcomes of multisite moderate to high dose radiotherapy for patients with metastatic melanoma Stereotactic radiotherapy: An educational narrative review Clinical application of high‐LET radiotherapy combined with immunotherapy in malignant tumors
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1